- Corporate Officers - N
- Nabel Elizabeth G
Insider Trading History of Nabel Elizabeth G
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nabel Elizabeth G since 2020.
This trader's CIK number is 1619929.
At the time of last reporting, Nabel Elizabeth G was the Director of Moderna, Inc.. (stock ticker symbol MRNA).
Also see all insider trading activities at Moderna, Inc..
Note that in the past
NABEL ELIZABETH G also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Accolade, Inc. (ACCD) by Nabel Elizabeth G
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | ACCD | 0 | $0 | 0 | $0 | 2,178 | $0 |
2024 | ACCD | 0 | $0 | 0 | $0 | 17,484 | $0 |
2023 | ACCD | 0 | $0 | 0 | $0 | 19,315 | $0 |
2022 | ACCD | 0 | $0 | 0 | $0 | 2,659 | $0 |
2021 | ACCD | 0 | $0 | 0 | $0 | 346 | $0 |
Yearly summary of insider trading at Moderna, Inc. (MRNA) by Nabel Elizabeth G
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | MRNA | 0 | $0 | 0 | $0 | 979 | $0 |
2024 | MRNA | 0 | $0 | 0 | $0 | 2,196 | $0 |
2023 | MRNA | 0 | $0 | 0 | $0 | 670 | $0 |
2022 | MRNA | 0 | $0 | 0 | $0 | 703 | $0 |
2020 | MRNA | 0 | $0 | 103,975 | $8,477,964 | 59,631 | $1,043,959 |
Insider trading activities at 2 companies by Nabel Elizabeth G:
1. Accolade, Inc. (ACCD)
2. Moderna, Inc. (MRNA)
Table 1. Insider trading of Accolade, Inc. (ACCD) by Nabel Elizabeth G
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-02-28 | ACCD | Option Ex | 2,178 | .00 | 0 |
2024-12-02 | ACCD | Option Ex | 2,179 | .00 | 0 |
2024-09-03 | ACCD | Option Ex | 2,179 | .00 | 0 |
2024-08-06 | ACCD | Option Ex | 9,196 | .00 | 0 |
2024-05-31 | ACCD | Option Ex | 2,179 | .00 | 0 |
2024-02-29 | ACCD | Option Ex | 1,751 | .00 | 0 |
2023-11-30 | ACCD | Option Ex | 1,751 | .00 | 0 |
2023-08-31 | ACCD | Option Ex | 1,752 | .00 | 0 |
2023-07-25 | ACCD | Option Ex | 14,060 | .00 | 0 |
2023-05-31 | ACCD | Option Ex | 1,752 | .00 | 0 |
2022-07-21 | ACCD | Option Ex | 2,659 | .00 | 0 |
2021-07-22 | ACCD | Option Ex | 346 | .00 | 0 |
Table 2. Insider trading of Moderna, Inc. (MRNA) by Nabel Elizabeth G
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-04-30 | MRNA | Option Ex | 979 | .00 | 0 |
2024-05-03 | MRNA | Option Ex | 732 | .00 | 0 |
2024-05-03 | MRNA | Option Ex | 732 | .00 | 0 |
2024-05-03 | MRNA | Option Ex | 732 | .00 | 0 |
2023-04-28 | MRNA | Option Ex | 670 | .00 | 0 |
2022-04-28 | MRNA | Option Ex | 703 | .00 | 0 |
2020-07-15 | MRNA | Option Ex | 59,631 | 17.51 | 1,043,959 |
2020-07-15 | MRNA | Sale | 73,975 | 87.84 | 6,497,964 |
2020-05-12 | MRNA | Sale | 30,000 | 66.00 | 1,980,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Nabel Elizabeth G
(Director of Moderna, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.